Working… Menu

A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03000257
Recruitment Status : Active, not recruiting
First Posted : December 22, 2016
Last Update Posted : May 4, 2021
Information provided by (Responsible Party):